Imaging of Ep-CAM Positive Metastatic Cancer in the Lymph System

Abstract

The majority of cancer mortalities occur not from the primary tumor but rather from distant metastases. Since the lymphatic system provides a route for the metastatic spread of cancer, it is not surprising that lymph node status serves as the primary prognostic indicator in most cancers. Currently, occult lymph node staging requires surgical removal of lymph nodes for subsequent biopsy, which in itself has significant morbidity. Specifically, in the case of breast cancer, axillary node resection is associated with an elevated risk of breast cancer-related lymphedema. This research plan aims to develop a unique imaging agent to identify metastatic tumor cells within the lymph nodes of cancer patients, initially with breast cancer patients. Development of a non-invasive methodology for nodal staging could eventually enable surgeons to intra-operatively differentiate cancer positive and negative lymph nodes, allowing for the specific resection of positive nodes and retention of cancer negative nodes.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Jan 01, 2011
Accession Number
ADA547589

Entities

People

  • Kristen Adams

Organizations

  • University of Texas Health Science Center at Houston

Tags

DTIC Thesaurus Topics

  • Amino Acids
  • Bandpass Filters
  • Biomedical Research
  • Breast Cancer
  • Cell Line
  • Cells
  • Charge Coupled Devices
  • Chelate Compounds
  • Culture Techniques
  • Department Of Defense
  • Detection
  • Fluorescence
  • Lymph Nodes
  • Lymphatic System
  • Medical Personnel
  • Molecules
  • Optics

Fields of Study

  • Medicine

Readers

  • Marine Ecological Systems Migration
  • Oncology (Cancer Research).
  • Women's Health and Cancer Risk Research: African American Women and Pregnancy Outcomes.